CRISPR-Cas9 knockdown of ESR1 in preoptic GABA-kisspeptin neurons suppresses the preovulatory surge and estrous cycles in female mice
Figures
![](https://iiif.elifesciences.org/lax:90959%2Felife-90959-fig1-v1.tif/full/617,/0/default.jpg)
CRISPR knockdown of ESR1 in preoptic GABA neurons.
(A, B) Photomicrographs showing distribution of mCherry (gRNA from AAV) and expression of GFP (Cas9) in VGAT neurons and nuclear-located ESR1 (blue) in the preoptic periventricular (PVpo) of two mice receiving either gRNA-LacZ (A) or gRNA-2 (B). The mCherry signal is removed in the adjoining plates (a) and (b) so that the VGAT neurons (green) co-expressing ESR1 (blue or teal nuclei) are more easily identified. Scale bar in (a) is the same for all photomicrographs. (C) Individual data points (n=6-9) and mean ± SEM percentage of GFP/VGAT neurons expressing ESR1 within injected regions of the RP3V and medial preoptic nuclei (MPN) for the three gRNA groups. ***p<0.001 versus gRNA-LacZ (ANOVA, post hoc Dunnett’s tests). Data in Source data 1. (D–G) Representative schematics of AAV injection sites (pink) in four mice; 16,337 (bilateral gRNA-2), 14,945 (unilateral RP3V, bilateral MPN gRNA-2), 13,631 (bilateral gRNA-3), 13,786 (bilateral gRNA-LacZ).
![](https://iiif.elifesciences.org/lax:90959%2Felife-90959-fig2-v1.tif/full/617,/0/default.jpg)
Deletion of ESR1 from preoptic GABA neurons and estrous cyclicity.
(A–C) Individual paired data points (n=6-7) and mean ± SEM estrous cycle length before and after AAV gRNA injection of lacZ, gRNA-2, and gRNA-3 into the RP3V and medial preoptic nuclei (MPN). (D–E) Individual paired data points (n=9-10) and mean ± SEM estrous cycle length before and after AAV gRNA injection in mice with bilateral AAV injections in the RP3V and MPN analyzed separately. Four mice (3× gRNA-2, 1× gRNA-3) enter constant estrus and one gRNA-2 mouse was in constant diestrus, all scored as a cycle length of 0. No significant effects of gRNA injection were detected (p>0.05 Wilcoxon paired tests). (F–H), Examples of estrous cycle patterns from three mice including one (G) that entered constant estrous following gRNA-2 injection. The individual animal number is given in each frame. All data in Source data 1.
![](https://iiif.elifesciences.org/lax:90959%2Felife-90959-fig3-v1.tif/full/617,/0/default.jpg)
Deletion of ESR1 from preoptic GABA neurons does not alter pulsatile luteinizing hormone (LH) secretion.
(A–D) Representative LH pulse profiles from female mice given AAV gRNA-lacZ, gRNA-2, and gRNA-3. The mouse identification number is given in brackets. (E–G) Histograms show the individual data points (n=5-6) and mean ± SEM for parameters of pulsatile LH secretion in mice given gRNA-lacZ, gRNA-2, and gRNA-3 into the RP3V and medial preoptic nuclei (MPN). No significant effects are detected (p>0.05, Kruskal-Wallis test). (H–J) Correlations between the % VGAT neurons with ESR1 in the RP3V and parameters of pulsatile LH secretion. Individual mice are color-coded according to their gRNA treatment. No significant correlations were detected (Pearson r<0.34 in all cases). (K–M) Correlations between the % VGAT neurons with ESR1 in the MPN and parameters of pulsatile LH secretion. Individual mice are color-coded according to their gRNA treatment. No significant correlations were detected (Pearson r<0.41 in all cases). All data in Source data 1.
![](https://iiif.elifesciences.org/lax:90959%2Felife-90959-fig4-v1.tif/full/617,/0/default.jpg)
Effects of ESR1 deletion in preoptic GABA neurons on surge parameters.
(A, B) Individual data points (n=6-7) and mean ± SEM values showing the percentage of gonadotropin-releasing hormone (GnRH) neurons with cFos and single-point luteinizing hormone (LH) levels for mice killed at the time of the expected surge given gRNA-LacZ (black), gRNA-2 (blue), and gRNA-3 (green) injections centered on the RP3V and medial preoptic nuclei (MPN). **p=0.0023 (Krusakl-Wallis) compared with LacZ. (C, D) Correlations between the % of RP3V VGAT neurons with ESR1 and cFos expression by GnRH neurons or LH secretion. Individual mice are color-coded according to their gRNA treatment. A significant correlation for cFos in GnRH neurons exists (p=0.008, Pearson r=0.66) but not for LH (p=0.26, Pearson r=0.31). (E, F) Correlations between the % of MPN VGAT neurons with ESR1 and cFos expression by GnRH neurons or LH secretion. Individual mice are color-coded according to their gRNA treatment. No significant correlations were found. All data in Source data 1.
![](https://iiif.elifesciences.org/lax:90959%2Felife-90959-fig5-v1.tif/full/617,/0/default.jpg)
Suppression of RP3V kisspeptin expression is associated with the loss of estrous cycles and the surge mechanism.
(A, B) Dual-label immunohistochemistry for kisspeptin (brown) and ESR1 (black) shows the normal high level of co-expression (white arrowheads) in a representative gRNA-lacZ mouse (A) but near absence of kisspeptin immunoreactivity in a representative ‘bilateral loss’ mouse (#16337) (B). 3V, third ventricle. Scale bar in B is the same for A. (C) Individual data points (n=4-7) and mean ± SEM values showing estrous cycle length before and after gRNA injection in gRNA ‘lacZ’ mice, gRNA-2/3 mice with ‘normal’ kisspeptin expression, gRNA-2/3 mice with a ‘unilateral’ reduction in kisspeptin, and gRNA-2/3 mice with a near-complete ‘bilateral’ loss of kisspeptin. *p<0.05 compared to pre-values. (D, E) Individual data points (n=4-7) and mean ± SEM single-point luteinizing hormone (LH) levels and % of gonadotropin-releasing hormone (GnRH) neurons with cFos at the time of the expected surge in gRNA ‘lacZ’ mice, gRNA-2/3 mice with ‘normal’ kisspeptin expression, gRNA-2/3 mice with a ‘unilateral’ reduction in kisspeptin, and gRNA-2/3 mice with a near-complete ‘bilateral’ loss of kisspeptin. *p<0.05 compared to lacZ. (F–H) Individual data points (n=3-7) and mean ± SEM parameters of pulsatile LH secretion in gRNA ‘lacZ’ mice, gRNA-2/3 mice with ‘normal’ kisspeptin expression, gRNA-2/3 mice with a ‘unilateral’ reduction in kisspeptin, and gRNA-2/3 mice with a near-complete ‘bilateral’ loss of kisspeptin. No significant differences were detected. All data in Source data 1.
Tables
Kisspeptin-ESR1 co-expression in re-grouped gRNA mice.
Table showing the numbers of kisspeptin neurons/section in the anteroventral periventricular (AVPV) and preoptic periventricular (PVpo) and percentage expression with ESR1. ‘LacZ’ refers to all mice given gRNA-LacZ, ‘normal’ refers to all gRNA-2/3 mice with normal kisspeptin expression (unilateral cell counts shown), ‘unilateral’ refers to gRNA-2/3 mice in which only one side of the brain had reduced kisspeptin cell numbers with the cell count on the affected side given, ‘bilateral’ refers to gRNA-2/3 mice with essentially no cytoplasmic kisspeptin expression bilaterally in the RP3V. Too few kisspeptin neurons existed to reliably determine co-expression with ESR1. **p<0.01, ***p<0.001 compared with lacZ group (Kruskal-Wallis with Dunn’s tests, exact p-values given below). All data in Source data 1.
LacZ (n=8) | Normal (n=7) | Unilateral(n=6) | Bilateral (n=4) | ||
---|---|---|---|---|---|
AVPV | No. kisspeptin neurons/section | 20.1±2.0 | 15.4±0.9 | 5.6±2.5** (p=0.0066) | 0.4±0.1*** (p=0.0006) |
% Kiss with ESR1 | 74.5±3.3 | 78.5±4.4 | 57.3±19.7 | – | |
PVpo | No. kisspeptin neurons/section | 24.0±1.9 | 19.6±1.3 | 4.8±2.8** (p=0.0016) | 0.8±0.3** (p=0.0031) |
% Kiss with ESR1 | 63.3±5.1 | 70.5±5.2 | 27.5±17.1 | – |
VGAT-ESR1 in mice grouped on the basis of kisspeptin expression.
Table showing the percentage of VGAT neurons in the RP3V and MPN expressing ESR1 in gRNA mice re-grouped on the basis of kisspeptin expression (see Table 1 for explanation of groups). *p<0.05, ***p<0.001 compared with lacZ group (Kruskal-Wallis with Dunn’s tests, exact p-values given below). All data in Source data 1.
LacZ (n=8) | Normal (n=7) | Unilateral (n=6) | Bilateral (n=4) | ||
---|---|---|---|---|---|
RP3V | % VGAT with ESR1 | 50.4±6.1 | 17.9±2.3* (p=0.0242) | 17.7±3.0* (p=0.0358) | 24.5±4.8 |
MPN | % VGAT with ESR1 | 61.2±4.2 | 14.0±3.1*** (p=0.0002) | 22.0±5.1* (p=0.0162) | 30.1±4.8 |
Additional files
-
Source data 1
All measured parameters for each individual mouse.
- https://cdn.elifesciences.org/articles/90959/elife-90959-data1-v1.xlsx
-
MDAR checklist
- https://cdn.elifesciences.org/articles/90959/elife-90959-mdarchecklist1-v1.docx